Par Drugs & Chemicals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

12.30

12.30

6.15

6.15

4.48

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

58.93

47.57

46.06

34.46

24.64

Loan funds

Secured loans

-

-

7.64

4.62

6.55

Unsecured loans

-

-

-

-

3.80

Total

71.24

59.88

59.85

45.23

39.47

Uses of funds

Fixed assets

Gross block

67.57

60.02

52.54

34.40

56.71

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

29.12

25.91

22.63

-

20.37

Net block

38.45

34.10

29.91

34.40

36.34

Capital work-in-progress

0.25

0.25

4.52

0.74

-

Investments

0.01

0.01

0.01

0.06

0.06

Net current assets

Current assets, loans & advances

50.16

44.33

41.94

24.92

14.96

Less : current liabilities & provisions

17.63

18.81

16.53

14.88

11.89

Total net current assets

32.53

25.52

25.41

10.04

3.07

Miscellaneous expenses not written

-

-

-

-

-

Total

71.24

59.88

59.85

45.23

39.47

Notes:

Book value of unquoted investments

-

-

-

0.06

0.06

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

0.24

0.24

0.20

Number of equity sharesoutstanding (Lacs)

123.05

123.05

61.52

61.52

44.80